Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro

Since the beginning of December 2019, a novel Coronavirus severe respiratory disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which also been termed 2019-new CoV (2019-nCoV), has continued to spread worldwide. As of August 27, 2020, a total of 24,232,429 people have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiangjun, Lu, Jiayu, Ge, Shuai, Hou, Yajing, Hu, Tian, Lv, Yuexin, Wang, Cheng, He, Huaizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081582/
https://www.ncbi.nlm.nih.gov/pubmed/33932547
http://dx.doi.org/10.1016/j.micpath.2021.104929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081582/
https://www.ncbi.nlm.nih.gov/pubmed/33932547
http://dx.doi.org/10.1016/j.micpath.2021.104929

Ejemplares similares